Value through Innovation27 July 2016

What is a lay summary?

Clinical Study Results

  • VARGATEF ® - Genital Neoplasms, Female
    Clinical Study Number 1199.6
    Study Indication Genital Neoplasms, Female
    Product VARGATEF ®
    Generic Name Nintedanib
    Lab Code
    Clinical Phase I
    Study Title

    Phase I trial of escalating doses of BIBF 1120 in combination with paclitaxel/carboplatin in patients with advanced gynaecological malignancies

    Study Document
    Trial synopsis 1199.6 english